Komodo Health Revenue, Valuation, Funding & Investors

Komodo Health is valued at $3.3B as of December 2022, a 22.0x multiple on its last reported $150M revenue.

Last Komodo Health valuation

$3.3B

Undisclosed stage · Dec 2022

Last Komodo Health funding round

$200M

Undisclosed stage · Dec 2022

Komodo Health revenue

$150M

Undisclosed stage · Dec 2022

Key investors in Komodo Health

  • Andreessen Horowitz
  • ICONIQ Capital
  • Tiger Global
  • Felicis
  • Coatue
  • Casdin Capital

Komodo Health Overview

About Komodo Health

Komodo Health is a San Francisco-headquartered platform that maps over 500 million patient journeys by integrating claims, clinical, and pharmacy data sources into its Healthcare Map. The system leverages AI and data science to deliver real-world evidence and market insights for life sciences companies, healthcare payers, and providers. Since its founding in 2014, it serves more than 1,500 life sciences organizations including major pharmaceutical firms in therapy development and commercialization. The company maintains a presence across the United States with additional offices in New York and Boston.


Founded

2014

HQ

United StatesSan Francisco, CA

Status

Privately held

Customer focus

B2B

Revenue model

Subscription

Revenue

$150M (Dec 2022)

Valuation

$3.3B (Dec 2022)

Komodo Health Valuation

Komodo Health is currently valued at $3.3B, based on its undisclosed-stage round in December 2022.

The $200M round was led by Coatue, with participation from Dragoneer.

Komodo Health's valuation has moved from $3.3B at its Series D in January 2021 to $3.3B in December 2022, across 3 priced rounds.

Komodo Health valuation by funding round

Revenue multiple
Komodo Health valuation by funding round
DateStageValuationRevenue Multiple
Dec 2022Undisclosed stage$3.3B22.0x
Mar 2021Series E$3.3B16.5x
Jan 2021Series D$3.3B22.0x

Komodo Health Revenue

Komodo Health's latest recorded revenue is $150M, as of its undisclosed-stage round in December 2022. At a $3.3B valuation, that implies a 22.0x revenue multiple.

Revenue moved from $150M in January 2021 to $150M in December 2022, while the revenue multiple moved from 22.0x to 22.0x.

Komodo Health revenue by funding round

Komodo Health revenue and valuation multiple by funding round
DateRevenue *ValuationRevenue MultipleStage
Dec 2022$150M$3.3B22.0xUndisclosed stage
Mar 2021$200M$3.3B16.5xSeries E
Jan 2021$150M$3.3B22.0xSeries D

* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.

Komodo Health Funding History

Komodo Health has raised a total of $514M across 4 funding rounds.

Komodo Health's first fundraising round was a $50M Series C in January 2020. The most recent completed round was a $200M undisclosed-stage round in December 2022.

Komodo Health funding rounds

Komodo Health funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Dec 2022Undisclosed stageCoatue (lead); Dragoneer$200M$3.3BKomodo Health is a San Francisco-based health data startup that provides comprehensive patient journey data and advanced software solutions for the healthcare industry. The company's platform, including products such as Healthcare Map and MapView, leverages AI and data science to deliver de-identified, patient-level insights that improve decision-making across life sciences, health plans, and healthcare providers. The company boasts that its map currently represents the industry's largest and most representative repository of connected healthcare insights. In November 2022, Komodo Health secured a structured equity infusion of $200 million led by Coatue Management with Dragoneer Investment Group contributing. The company had previously raised $314 million across earlier rounds, including a $220 million Series E in March 2021 that valued the company at $3.3 billion. As of March 2022, the company reported an ARR of approximately $150 million and was growing its top line at a rate of more than 50% while maintaining SaaS-like margins, though it was not yet profitable. Following the November 2022 funding, the company announced a 9% workforce reduction and departing CFO to navigate uncertain macroeconomic conditions. The company had previously been considered IPO-ready, with co-founders expressing interest in going public, but delayed those plans citing market conditions.
Mar 2021Series ETiger Global (lead); SVB Capital; ICONIQ Capital; Casdin Capital; Andreessen Horowitz$220M$3.3BKomodo Health is a San Francisco and New York-based healthcare data analytics platform founded in 2014 that integrates de-identified patient data with software solutions to provide healthcare intelligence across the enterprise. The company's core product, the Healthcare Map, leverages artificial intelligence and advanced data analytics to track healthcare encounters for over 325 million de-identified patients, providing what the company describes as the industry's largest and most complete record of real-world patient insights. The platform serves healthcare providers, pharmaceutical companies, and life sciences stakeholders with services designed to close gaps in care, address unmet patient needs, improve patient engagement, and accelerate the path to market for novel therapies. In March 2021, Komodo Health closed a $220 million Series E funding round led by Tiger Global Management, with participation from new investor Casdin Capital and existing backers ICONIQ Growth, Andreessen Horowitz, and Silicon Valley Bank Capital, valuing the company at $3.3 billion post-money. The company planned to deploy the capital to accelerate investment in its Healthcare Map enterprise technology platform, application suite, and core data assets as digital adoption accelerated across healthcare. Prior to this round, Komodo had raised $44 million in a previously undisclosed Series D during 2020 and $50 million in a Series C in January 2020, accumulating over $300 million in total funding by the time of the Series E announcement.
Jan 2021Series DICONIQ Capital$44M$3.3BKomodo Health is a San Francisco-based healthcare analytics platform that aggregates de-identified patient data from payers and providers to track over 325 million patients' journeys through the healthcare system, enabling biopharma, health plans, and providers to analyze real-world outcomes, close care gaps, and accelerate therapies to market using AI and advanced analytics like its Healthcare Map. In March 2021, Komodo Health raised $220 million in a Series E round led by Tiger Global with participation from Casdin Capital (new), Andreessen Horowitz, ICONIQ Growth, and SVB Capital, achieving a post-money valuation exceeding $3.3 billion; funds were allocated to enhance its technology platform, data completeness, and workflow integrations. An unpublicized Series D of $44 million occurred in 2020, with ICONIQ Growth involved, followed by the $50 million Series C in January 2020. The company acquired Mavens in January 2021 to bolster commercialization tools for biotech and rare disease pharma, and Breakaway Partners in July 2021. Later 2022 revenue reached $150 million per one source. Komodo has raised over $515 million total across eight rounds, with subsequent unattributed rounds including $200 million in November 2022 and another in June 2022. It serves major biopharma like Karyopharm for COVID-19 insights and partners with groups like the Cholangiocarcinoma Foundation. The firm competes in a hot analytics market, alongside players like Clarify Health ($115M Series C) and Unite Us ($150M), focusing on patient-centric data to outpace legacy aggregators amid growing investor interest in life sciences tech.
Jan 2020Series CAndreessen Horowitz (lead); Felicis; IA Ventures; Oak HC/FT$50M-Komodo Health is a healthcare technology and data analytics platform company founded in 2014, headquartered in San Francisco. The company uses de-identified and cross-linked patient data, proprietary Healthcare Map technology, and AI-powered software to provide real-world data and analytics for life sciences, payers, providers, and healthcare organizations. As of 2020, the company served major biopharmaceutical clients including Johnson & Johnson, Merck, Novo Nordisk, and Pfizer. Komodo Health generated $118.3 million in revenue for the year ended December 31, 2020, representing 38% year-over-year growth from $85.5 million in 2019. The company's most recent disclosed funding milestone was a $220 million Series E round in March 2021 led by Tiger Global Management and Casdin Capital, which valued the company at $3.3 billion post-money. As of December 2025, Komodo Health had raised $514 million cumulatively across multiple funding rounds. By 2022, the company had achieved SaaS-like margins and was growing its annual recurring revenue at more than 50%, with ARR of approximately $150 million, though it was not yet profitable at that time. By 2024, the company's customer base had expanded to include over 200 life sciences and healthcare organizations utilizing its product suite.

Who has invested in Komodo Health?

10 investors have backed Komodo Health across its funding rounds, including Andreessen Horowitz, ICONIQ Capital, Tiger Global, Felicis, Coatue and Casdin Capital.

Lead investors include Coatue, Tiger Global and Andreessen Horowitz.


Komodo Health Investors

Investors in Komodo Health by funding rounds participated
InvestorHQRoundsRoleFirst check
ICONIQ CapitalUnited StatesSan Francisco, CA2ParticipantJan 2021
Andreessen HorowitzUnited StatesSan Francisco, CA2LeadJan 2020
DragoneerUnited StatesSan Francisco, CA1ParticipantDec 2022
SVB CapitalUnited StatesSan Francisco, CA1ParticipantMar 2021
Casdin CapitalUnited StatesNew York City, NY1ParticipantMar 2021
FelicisUnited StatesSan Francisco, CA1ParticipantJan 2020
IA VenturesUnited StatesUnited States1ParticipantJan 2020
Oak HC/FTUnited StatesGreenwich, CT1ParticipantJan 2020

This data is available for Pro users. Sign up to see all 10 Komodo Health investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Acquisitions by Komodo Health

Komodo Health has acquired 2 companies to date.

Last acquisition by Komodo Health was on July 26th 2021. Komodo Health acquired Breakaway Partners for undisclosed valuation.


Latest Acquisitions by Komodo Health

Breakaway Partners
Mavens
Description
Breakaway Partners is a data intelligence provider unifying pharma sales, operations, and marketing metrics for life sciences firms. It delivers targeting platforms with HCP engagement scores and pull-through analytics. Raleigh-headquartered since 2005, Breakaway Partners equips teams with accurate datasets covering U.S. territories.
Mavens is a Salesforce implementation partner serving the life sciences sector with Force.com and Veeva CRM solutions. It customizes platforms for pharmaceutical and medical device companies to manage commercial operations, compliance, and field activities. Founded in 2007, the Chicago-headquartered firm operates offices across the United States and Europe, supporting global deployments for clients like Pfizer and Johnson & Johnson.
HQ CountryUnited StatesUnited States
HQ City
Morristown, NJ
Chicago, IL
Deal Date26 Jul 202111 Jan 2021
Valuationundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Komodo Health acquisitions and their M&A valuation multiples.

Start Free Trial

Komodo Health Competitors

Komodo Health competitors include listed companies like Tempus AI and GeneDx, and private ones like Hippocratic AI, Black Forest Labs, Certus Core and AfterQuery.

Public and private companies comparable to Komodo Health
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
Hippocratic AIUnited StatesSan Francisco, CAPrivate--$3.5B-
Tempus AIUnited StatesUnited StatesPublicly listed$1.3B($131M)$15B10.1x
Black Forest LabsGermanyFreiburg im BreisgauPrivate$96M-$3.3B33.9x
Certus CoreUnited StatesTampa, FLPrivate--$3.4B-
AfterQueryUnited StatesSan Francisco, CAPrivate$100M-$3.2B32.0x
GeneDxUnited StatesUnited StatesPublicly listed$428M$7M$3.1B6.8x

Komodo Health Public Comps

Komodo Health is still privately-owned, but its public comps include GeneDx, XtalPi, CareDx, Privia Health, Clover Health, Affle 3i, Ncino, Haizhi, C3.ai and Presight AI.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
GeneDx$428M$7M7.4x6.8x477.6x183.5x
XtalPi$120M$22M24.8x21.5x134.0x(141.6x)
CareDx$380M($10M)6.5x5.3x(249.3x)41.0x
Privia Health$2.1B$44M1.0x0.9x50.2x15.3x
Clover Health$1.9B($84M)1.1x0.8x(25.8x)34.1x
Affle 3i$282M$67M7.4x6.7x31.3x29.5x
Ncino$595M$65M4.3x4.0x39.0x15.8x
Haizhi$93M($30M)21.5x16.3x(67.1x)(440.4x)

This data is available for Pro users. Sign up to see all Komodo Health competitors and their valuation data.

Start Free Trial

Common questions about Komodo Health

When was Komodo Health founded?Komodo Health was founded in 2014.
Where is Komodo Health headquartered?Komodo Health is headquartered in San Francisco, CA, United States.
Is Komodo Health publicly listed?No, Komodo Health is a private, VC-backed company.
What is Komodo Health's valuation?Komodo Health was last valued at $3.3B in its undisclosed-stage round in December 2022.
How much funding has Komodo Health raised?Komodo Health has raised $514M across 4 funding rounds.
What was Komodo Health's last funding round?Komodo Health's last funding round was a $200M undisclosed-stage round in December 2022, led by Coatue.
Who are Komodo Health's investors?Komodo Health's investors include ICONIQ Capital, Andreessen Horowitz, Dragoneer, SVB Capital, Casdin Capital, Felicis, IA Ventures, Oak HC/FT, Tiger Global and Coatue.
What is Komodo Health's revenue?Komodo Health's latest recorded revenue is $150M (December 2022).
What is Komodo Health's revenue multiple?Komodo Health's latest valuation implies a 22.0x revenue multiple ($3.3B valuation on $150M of revenue).
Which companies are comparable to Komodo Health?Companies comparable to Komodo Health include Hippocratic AI, Tempus AI, Black Forest Labs, Certus Core, AfterQuery and GeneDx.
How many companies has Komodo Health acquired?Komodo Health has acquired 2 companies, including Breakaway Partners and Mavens.

See companies similar to Komodo Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial